Reference health
Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
43/43 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 43 checked references that resolve
resolves10.1111/j.1600-0404.1989.tb01778.x
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
resolves10.1093/brain/114.5.2283
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
resolves10.1126/science.276.5321.2045
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
resolves10.1038/ng.487
Genome-wide association study reveals genetic risk underlying Parkinson's disease
resolves10.1038/ng.485
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
resolves10.1523/JNEUROSCI.1731-12.2012
Conditional Expression of Parkinson's Disease-Related Mutant -Synuclein in the Midbrain Dopaminergic Neurons Causes Progressive Neurodegeneration and Degradation of Transcription Factor Nuclear Receptor Related 1
resolves10.1073/pnas.91.16.7772
High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system.
resolves10.1124/pr.59.2.1
Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase
resolves10.1021/tx9000557
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
resolves10.1073/pnas.1220399110
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
resolves10.1016/j.brainres.2011.06.051
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system
resolves10.1371/journal.pone.0031522
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
resolves10.1126/science.1063522
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
resolves10.1007/s00401-007-0303-9
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
resolves10.1172/JCI15777
Misfolded proteinase K–resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies
resolves10.1523/JNEUROSCI.0285-07.2007
Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity<i>In Vivo</i>
resolves10.1016/j.cell.2012.03.037
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
resolves10.1016/j.nbd.2003.09.001
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia
resolves10.1523/JNEUROSCI.04-01-00111.1984
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization
resolves10.1128/MCB.23.13.4637-4648.2003
Targeted Disruption of <i>Aldh1a1</i> (<i>Raldh1</i>) Provides Evidence for a Complex Mechanism of Retinoic Acid Synthesis in the Developing Retina
resolves10.1016/j.cbi.2011.01.006
Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease
resolves10.1007/s12031-011-9688-y
Modulation of Aldehyde Dehydrogenase Activity Affects (±)-4-Hydroxy-2E-nonenal (HNE) Toxicity and HNE–Protein Adduct Levels in PC12 Cells
resolves10.1523/JNEUROSCI.22-07-02637.2002
Caspase Inhibitors Attenuate 1-Methyl-4-Phenylpyridinium Toxicity in Primary Cultures of Mesencephalic Dopaminergic Neurons
resolves10.1523/JNEUROSCI.15-05-03318.1995
Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation
resolves10.1083/jcb.134.3.757
Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
resolves10.1016/j.neuron.2009.11.006
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
resolves10.1016/S1474-4422(07)70246-6
Calcium, ageing, and neuronal vulnerability in Parkinson's disease
resolves10.1074/jbc.R112.410530
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
resolves10.1111/jnc.12345
Determinants of buildup of the toxic dopamine metabolite<scp>DOPAL</scp>in Parkinson's disease
resolves10.1371/journal.pone.0011464
A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
resolves10.1002/jnr.22611
Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein
resolves10.1242/dev.02865
Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency
resolves10.1111/jnc.12160
The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress
resolves10.1126/science.274.5293.1678
Control of Memory Formation Through Regulated Expression of a CaMKII Transgene
resolves10.1007/s10561-008-9067-2
The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
resolves10.1016/j.nbd.2007.11.011
Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function
resolves10.1523/JNEUROSCI.2795-06.2006
Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice
The 3 references without a DOI — listed, not checked
no DOI — not checkedB1
no DOI — not checkedFranklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 3rd ed. Waltham, Massachusetts, USA: Academic Press; 2008.
no DOI — not checkedMai JK, Paxinos G, Voss T. Atlas Of The Human Brain. 3rd ed. Waltham, Massachusetts, USA: Academic Press; 2007.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1172/jci72176"><img src="https://citestamp.com/citestamped/10.1172/jci72176/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1172/jci72176)